hormone therapy

The Trump administration has asked the Supreme Court to let it deny hormone therapy to transgender inmates, in a move reported by the New York Times. The filing asks the justices to intervene in litigation over prison healthcare for transgender people. The request is drawing attention from civil rights advocates and reigniting debate over transgender rights and the treatment of incarcerated people under the administration.

The Trump administration has asked the US Supreme Court to let it deny hormone therapy to transgender inmates in federal custody. The request escalates a legal fight over medical care for transgender prisoners, pitting claims of institutional discretion and public cost against court rulings that withholding such treatment violates the constitutional ban on cruel and unusual punishment. The justices' response will shape how far correctional authorities must go in providing gender-affirming care behind bars.

Researchers report that biological characteristics of prostate cancer tumours can help identify which patients are most likely to benefit from hormone therapy. The finding suggests tumour biology could be used to tailor treatment decisions rather than applying hormone therapy uniformly. Details of the study, including sample size and clinical impact, were not provided, but the work points toward more personalised prostate cancer care.